niacinamide has been researched along with Cardiomyopathies in 14 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The myocardial protective effect of nicorandil, N-(2-hydroxyethyl) nicotinamide nitrate ester, against hypoxia was examined in comparison with that of nitroglycerin in 22 open chest dogs." | 3.67 | Examination of the direct effects of antianginal agents on the hypoxic canine myocardium. ( Hattori, S; Kojima, S; Miyamori, R; Miyazaki, T; Mori, H; Nagata, M; Nakamura, Y; Takahashi, M, 1987) |
| "augusta leaves (AA) against type 2 diabetes mellitus (T2DM) and its associated nephropathy and cardiomyopathy in experimental rats." | 1.42 | Abroma augusta L. (Malvaceae) leaf extract attenuates diabetes induced nephropathy and cardiomyopathy via inhibition of oxidative stress and inflammatory response. ( De Feo, V; Dewanjee, S; Gangopadhyay, M; K Dua, T; Khanra, R; Sahu, R; Zia-Ul-Haq, M, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (28.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Podyacheva, E | 2 |
| Toropova, Y | 2 |
| N Yu, N | 1 |
| V A, V | 1 |
| Mukhametdinova, D | 1 |
| Goncharova, I | 1 |
| Zelinskaya, I | 1 |
| Sviridov, E | 1 |
| Martynov, M | 1 |
| Osipova, S | 1 |
| Zhang, Y | 1 |
| Li, Y | 1 |
| Hu, Q | 1 |
| Xi, Y | 1 |
| Xing, Z | 1 |
| Zhang, Z | 1 |
| Huang, L | 1 |
| Wu, J | 1 |
| Liang, K | 1 |
| Nguyen, TK | 1 |
| Egranov, SD | 1 |
| Sun, C | 1 |
| Zhao, Z | 1 |
| Hawke, DH | 1 |
| Li, J | 1 |
| Sun, D | 1 |
| Kim, JJ | 1 |
| Zhang, P | 1 |
| Cheng, J | 1 |
| Farida, A | 1 |
| Hung, MC | 1 |
| Han, L | 1 |
| Darabi, R | 1 |
| Lin, C | 1 |
| Yang, L | 1 |
| Vignier, N | 1 |
| Chatzifrangkeskou, M | 1 |
| Morales Rodriguez, B | 1 |
| Mericskay, M | 1 |
| Mougenot, N | 1 |
| Wahbi, K | 1 |
| Bonne, G | 1 |
| Muchir, A | 1 |
| Khanra, R | 1 |
| Dewanjee, S | 1 |
| K Dua, T | 1 |
| Sahu, R | 1 |
| Gangopadhyay, M | 1 |
| De Feo, V | 1 |
| Zia-Ul-Haq, M | 1 |
| Xu, W | 1 |
| Barrientos, T | 1 |
| Mao, L | 1 |
| Rockman, HA | 1 |
| Sauve, AA | 1 |
| Andrews, NC | 1 |
| Saad, NS | 1 |
| Floyd, K | 1 |
| Ahmed, AA | 1 |
| Mohler, PJ | 1 |
| Janssen, PM | 1 |
| Elnakish, MT | 1 |
| Kashuro, VA | 1 |
| Glushkov, SI | 1 |
| Novikova, TM | 1 |
| Aksenov, VV | 1 |
| Uraizee, I | 1 |
| Cheng, S | 1 |
| Moslehi, J | 1 |
| Park, H | 1 |
| Han, SH | 1 |
| Kang, H | 1 |
| Park, K | 1 |
| Gross, GJ | 1 |
| Pieper, GM | 1 |
| Nakamura, Y | 1 |
| Kojima, S | 1 |
| Mori, H | 1 |
| Nagata, M | 1 |
| Miyazaki, T | 1 |
| Miyamori, R | 1 |
| Hattori, S | 1 |
| Takahashi, M | 1 |
| Nurmukhambetov, AN | 1 |
| Riabtseva, TA | 1 |
| Reid, JV | 1 |
| Berjak, P | 1 |
1 review available for niacinamide and Cardiomyopathies
| Article | Year |
|---|---|
Nicotinamide Riboside for the Prevention and Treatment of Doxorubicin Cardiomyopathy. Opportunities and Prospects.
Topics: Animals; Antibiotics, Antineoplastic; Biomarkers; Cardiomyopathies; Cardiotonic Agents; Cardiotoxici | 2021 |
13 other studies available for niacinamide and Cardiomyopathies
| Article | Year |
|---|---|
Intravenous Nicotinamide Riboside Administration Has a Cardioprotective Effect in Chronic Doxorubicin-Induced Cardiomyopathy.
Topics: Animals; Cardiomyopathies; Doxorubicin; Male; NAD; Niacinamide; Pyridinium Compounds; Rats; Rats, Wi | 2022 |
The lncRNA H19 alleviates muscular dystrophy by stabilizing dystrophin.
Topics: Animals; Antipyrine; Cardiomyopathies; Cell Line; Disease Models, Animal; Dystrophin; Enzyme Inhibit | 2020 |
Rescue of biosynthesis of nicotinamide adenine dinucleotide protects the heart in cardiomyopathy caused by lamin A/C gene mutation.
Topics: Animals; Cardiomyopathies; Disease Models, Animal; Heart; Heart Failure; Heart Ventricles; Humans; L | 2018 |
Abroma augusta L. (Malvaceae) leaf extract attenuates diabetes induced nephropathy and cardiomyopathy via inhibition of oxidative stress and inflammatory response.
Topics: Adenosine Triphosphate; Animals; Biomarkers; Blood Glucose; Body Weight; Cardiomyopathies; Diabetes | 2015 |
Lethal Cardiomyopathy in Mice Lacking Transferrin Receptor in the Heart.
Topics: Animals; Cardiomyopathies; Cell Respiration; Iron; Mice; Mitophagy; Myocardium; Niacinamide; Pyridin | 2015 |
The Effect of Sorafenib, Tadalafil and Macitentan Treatments on Thyroxin-Induced Hemodynamic Changes and Cardiac Abnormalities.
Topics: Animals; Blood Pressure; Cardiomyopathies; Disease Models, Animal; Echocardiography; Electrocardiogr | 2016 |
[Cardioprotective effect of cytoflavine on a model of doxorubicin-induced cardiomyopathy].
Topics: Animals; Cardiomyopathies; Cardiotonic Agents; Cytoprotection; Doxorubicin; Drug Combinations; Eryth | 2010 |
Reversible cardiomyopathy associated with sunitinib and sorafenib.
Topics: Aged; Antineoplastic Agents; Benzenesulfonates; Cardiomyopathies; Female; Humans; Indoles; Male; Mid | 2011 |
A case of reversible cardiomyopathy associated with sorafenib in advanced hepatocellular carcinoma.
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Cardiomyopathies; Coronary Angiography; Fema | 2012 |
Effect of cyclooxygenase blockade on the beneficial actions of nicorandil in the stunned myocardium of dogs.
Topics: Animals; Blood Pressure; Cardiomyopathies; Coronary Circulation; Cyclooxygenase Inhibitors; Dinopros | 1989 |
Examination of the direct effects of antianginal agents on the hypoxic canine myocardium.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Cardiomyopathies; Coronary Circulation; Dogs | 1987 |
[Prevention of disorders of cardiac contractility with nicotinamide in adriblastin -related damage].
Topics: Animals; Cardiomyopathies; Doxorubicin; Heart Failure; Hypoxia; Myocardial Contraction; Niacinamide; | 1988 |
Dietary production of myocardial fibrosis in the rat.
Topics: Animals; Cardiomyopathies; Dietary Fats; Dietary Proteins; Niacinamide; Pyridoxine; Rats; Tryptophan | 1966 |